Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Gross PP&E Adjustments (2018 - 2025)

Arcturus Therapeutics Holdings' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at -$1.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 65.23% year-over-year to -$1.9 million; the TTM value through Dec 2025 reached -$1.9 million, up 65.23%, while the annual FY2025 figure was -$1.9 million, 65.23% up from the prior year.
  • Other Gross PP&E Adjustments reached -$1.9 million in Q4 2025 per ARCT's latest filing, up from -$4.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $6.8 million in Q1 2022 to a low of -$20.7 million in Q2 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$5.9 million, with a median of -$5.8 million recorded in 2024.
  • The largest YoY upside for Other Gross PP&E Adjustments was 6222.43% in 2022 against a maximum downside of 2965.01% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $4.3 million in 2021, then tumbled by 435.13% to -$14.3 million in 2022, then skyrocketed by 48.89% to -$7.3 million in 2023, then rose by 27.29% to -$5.3 million in 2024, then surged by 65.23% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Other Gross PP&E Adjustments are -$1.9 million (Q4 2025), -$4.4 million (Q3 2025), and -$3.3 million (Q2 2025).